Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.34 |
| ▸ | ACHE | P22303 | 6/20 | 0.34 |
| ▸ | BCHE | P06276 | 5/20 | 0.34 |
| ▸ | NQO1 | P15559 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | APLNR | P35414 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5670902 | 1.00 | LMNA (0.63) | LMNAL3MBTL1THRBPKMPTGS2 | |
| Benzoquinone SCHEMBL18838186 | 0.82 | LMNA (0.60) | LMNAL3MBTL1THRBPKMPTGS2 | |
| SCHEMBL9459 | 0.80 | — | — | |
| SCHEMBL2094168 | 0.80 | LMNA (1.00) | LMNATHRB | |
| SCHEMBL2698061 | 0.79 | LMNA (0.63) | LMNATHRBPTGS2ACHEBCHE | |
| SCHEMBL4918898 | 0.78 | LMNA (0.55) | LMNAL3MBTL1 | |
| Formaldehyde SCHEMBL209588 | 0.77 | LMNA (0.80) | LMNATHRB | |
| Naphthoquinone SCHEMBL6917183 | 0.77 | CDC25B (0.54) | LMNAL3MBTL1THRBPKMPTPRC | |
| SCHEMBL5105333 | 0.76 | — | — | |
| SCHEMBL3453066 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8157469-A | — | — | None | — | — | JP | disclosed |
| JP-8198869-A | — | — | None | — | — | JP | disclosed |
| JP-8198869-A | — | — | None | — | — | JP | disclosed |
| JP-8198868-A | — | — | None | — | — | JP | disclosed |
| JP-8198868-A | — | — | None | — | — | JP | disclosed |
| EP-3978537-B1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | UNIV TOKYO (JP) | 2023-09-13 | — | — | EP | disclosed |
| CN-113874402-B | Polar group-containing olefin copolymer | 国立大学法人东京大学 | 2023-04-04 | — | — | CN | disclosed |
| US-20220220239-A1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | THE UNIVERSITY OF TOKYO (JP) | 2022-07-14 | — | — | US | disclosed |
| WO-2020241715-A1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | 国立大学法人東京大学 | 2020-12-03 | — | — | WO | disclosed |
| US-8541625-B2 | Cyclopropenones and the photochemical generation of cyclic alkynes therefrom | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2013-09-24 | — | — | US | disclosed |
| EP-1069107-B1 | FULLERENE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 2005-05-11 | — | — | EP | disclosed |
| US-20040214218-A1 | Fullerene derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-10-28 | — | — | US | disclosed |
| US-6765098-B1 | DNA COMPACTION; GENE THERAPY | FUJISAWA PHARMACEUTICAL CO., LTD (JP) | 2004-07-20 | — | — | US | disclosed |
| EP-1420066-A2 | Use of fullerene derivatives as DNA compaction agent | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-05-19 | — | — | EP | disclosed |
| EP-1069107-A1 | FULLERENE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-01-17 | — | — | EP | disclosed |
| JP-H08198869-A | PRODUCTION OF CYCLOPROPENONE ACETAL DERIVATIVE | MITSUBISHI CHEM CORP | 1996-08-06 | — | — | JP | disclosed |
| JP-H08198869-A | PRODUCTION OF CYCLOPROPENONE ACETAL DERIVATIVE | MITSUBISHI CHEM CORP | 1996-08-06 | — | — | JP | disclosed |
| JP-H08198868-A | PRODUCTION OF CYCLOPROPENONE ACETAL DERIVATIVE | MITSUBISHI CHEM CORP | 1996-08-06 | — | — | JP | disclosed |
| JP-H08198868-A | PRODUCTION OF CYCLOPROPENONE ACETAL DERIVATIVE | MITSUBISHI CHEM CORP | 1996-08-06 | — | — | JP | disclosed |
| JP-H08157469-A | PRODUCTION OF CYCLOPROPANONE ACETAL DERIVATIVE | MITSUBISHI CHEM CORP | 1996-06-18 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214218-A1 | Fullerene derivatives | RCC1, TOP2A, DNAH12 | LMNA 444/4885L3MBTL1 307/4885THRB 3682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.